Evolus
EOLS
$13.32
Share price
0.76%
Change (1 day)
60.87%
Change (1 year)
Categories
Revenue for Evolus (EOLS)
Revenue in 2023 (TTM): $0.20 B
According to Evolus
's latest financial reports the company's current revenue (TTM
) is $0.20 B.
In 2022 the company made a revenue of $0.14 B an increase over the years 2021 revenue that were of $99.67 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Evolus from 2017 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $0.20 B | 35.98% |
| 2022 | $0.14 B | 49.1% |
| 2021 | $99.67 M | 76.29% |
| 2020 | $56.54 M | 61.89% |
| 2019 | $34.92 M | |
| 2018 | N/A | |
| 2017 | N/A |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | N/A | N/A | 🇺🇸 USA |